Ligand · BD9
BD9 · N-undecanoyl-L-histidyl-L-histidyl-N-methyl-N-(2-pyridin-2-ylethyl)-L-tyrosinamide
BD9, N-undecanoyl-L-histidyl-L-histidyl-N-methyl-N-(2-pyridin-2-ylethyl)-L-tyrosinamide (C40 H55 N9 O5, 741.9 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…
- Component
- BD9
- Formula
- C40 H55 N9 O5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
BD9 in 2 structures; the first of them:
- 3HXF · Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 32) · BD9 B334 · binds ASP61, TYR44, LEU45, SER48, TYR51, TRP52, LEU96, TYR97 and 19 more
- 3HXF · Engineered rabggtase in complex with a peptidomimetic inhibitor (compound 32) · BD9 B334 · binds ASP61, TYR44, LEU45, SER48, TYR51, TRP52, LEU96, TYR97 and 19 more
Residues it binds most
TYR 2, CYS 2, PHE 2, LEU 2, ASP 2, HIS 2, SER 2, TRP 2, ARG 2, GLN 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.